An ongoing open-label phase 1/2a study of the safety and efficacy of melphalan-flufenamide (melflufen) and dexamethasone combination for patients with relapsed and relapsed-refractory multiple myeloma

U-H Mellqvist, C Paba-Prada, A Palumbo, Torben Plesner, P Sonneveld, P Voorhees, C Byrne, J Harmenberg, E Nordström, P. Richardson

Research output: Contribution to conference without publisher/journalConference abstract for conferenceResearchpeer-review

Original languageEnglish
Publication date2014
Publication statusPublished - 2014
EventAnnual Congress of the European Hematology Association - Milano, Italy
Duration: 12. Jun 201415. Jun 2014
Conference number: 19

Conference

ConferenceAnnual Congress of the European Hematology Association
Number19
Country/TerritoryItaly
CityMilano
Period12/06/201415/06/2014

Cite this